Insilico Medicine Hong Kong Limited
We are an end-to-end, artificial intelligence-driven pharma-technology company with a mission to accelerate drug discovery and development by leveraging our rapidly evolving, proprietary platform across biology, chemistry and clinical development.
See below for the Latest Insilico Medicine Hong Kong Limited News, Analysis, Profit Results, Share Price Information, and Commentary.
AI-driven drug discovery company Insilico Medicine Hong Kong Limited clinches an award at the HKB Technology Excellence Awards
AI-driven drug discovery company Insilico Medicine Hong Kong Limited clinches an award at the HKB Technology Excellence Awards
It has been delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, and ageing-related diseases.
Read Here
Advertise
Sign Up
Commentary
Hong Kong universities drive market shift: strategic acquisitions for student housing
Innovation at a Crossroads: Hong Kong's Needed Tech Transformation
Paving the way for a more integrated and efficient mobility future in Hong Kong